{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["077e76dd-b2a4-4e48-83a8-7f4fdcaa79d0", "MT", 72111, "AVENUE SOLUTIONS", 165778, "EPIX PHARMACEUTICALS", 2007, "mid_year", "2007-04-25T16:33:16-04:00", 40000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/077e76dd-b2a4-4e48-83a8-7f4fdcaa79d0/\", \"filing_uuid\": \"077e76dd-b2a4-4e48-83a8-7f4fdcaa79d0\", \"filing_type\": \"MT\", \"filing_type_display\": \"Mid-Year Termination\", \"filing_year\": 2007, \"filing_period\": \"mid_year\", \"filing_period_display\": \"Mid-Year (Jan 1 - Jun 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/077e76dd-b2a4-4e48-83a8-7f4fdcaa79d0/print/\", \"filing_document_content_type\": \"application/pdf\", \"income\": \"40000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": null, \"dt_posted\": \"2007-04-25T16:33:16-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": \"United States of America\", \"registrant_address_1\": null, \"registrant_address_2\": null, \"registrant_different_address\": null, \"registrant_city\": null, \"registrant_state\": null, \"registrant_zip\": null, \"registrant\": {\"id\": 72111, \"url\": \"https://lda.senate.gov/api/v1/registrants/72111/\", \"house_registrant_id\": 35940, \"name\": \"AVENUE SOLUTIONS\", \"description\": \"Government representation\", \"address_1\": \"401 9th St. NW\", \"address_2\": \"Suite 720\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20004\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"AMY TEJRAL\", \"contact_telephone\": \"+1 202-347-9848\", \"dt_updated\": \"2026-01-30T17:55:20.768017-05:00\"}, \"client\": {\"id\": 165778, \"url\": \"https://lda.senate.gov/api/v1/clients/165778/\", \"client_id\": 238, \"name\": \"EPIX PHARMACEUTICALS\", \"general_description\": null, \"client_government_entity\": null, \"client_self_select\": null, \"state\": \"MA\", \"state_display\": \"Massachusetts\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"MA\", \"ppb_state_display\": \"Massachusetts\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2007-04-25\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"FDA new drug application review\", \"foreign_entity_issues\": null, \"lobbyists\": [{\"lobbyist\": {\"id\": 23462, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"TRACY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"SPICER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"N/A\", \"new\": null}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["077e76dd-b2a4-4e48-83a8-7f4fdcaa79d0"], "units": {}, "query_ms": 37.13863412849605, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}